Cyclooxygenase 2 in Gastric Carcinoma Is Expressed in Doublecortin- and CaM Kinase-Like-1-Positive Tuft Cells
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Doublecortin and CaM kinase-like-1(DCAMKL1) is a marker of stem cells expressed predominantlyin the crypt base in the intestine. However, DCAMKL1-positive cells have been shown to be differentiated tuft cellsrather than quiescent progenitors. Tuft cells are the onlyepithelial cells that express cyclooxygenase 2 (COX-2) in thenormal intestinal epithelium. We previously generated Cdx2-transgenic mice as model mice for intestinal metaplasia andgastric carcinoma. In the current study, we investigated theassociation between COX-2 and DCAMKL1 in gastric carcinoma. Methods: We examined the association between COX-2 and DCAMKL1 expression in gastric carcinomas in clinicalsamples (early gastric well-differentiated adenocarcinoma)and Cdx2-transgenic mice; and the DCAMKL1-transgenicmouse stomach using immunohistochemistry and quantitativereal-time polymerase chain reaction. Results: The COX-2-expressing cells were scattered, not diffusely expressed, ingastric carcinomas from humans and Cdx2-transgenic mice. DCAMKL1-positive cells were also scattered in the gastriccarcinomas, indicating that tuft cells could still be presentin gastric carcinoma. COX-2 was expressed in DCAMKL1-positive tuft cells in Cdx2- and DCAMKL1-transgenic mousestomachs, whereas the Sox9 transcription factor was ubiquitouslyexpressed in gastric carcinomas, including COX-2-positive cells. Conclusions: COX-2 is expressed in DCAMKL1-expressing quiescent tuft cells in gastric carcinoma.
Abstract
Background/Aims: Doublecortin and CaM kinase-like-1(DCAMKL1) is a marker of stem cells expressed predominantlyin the crypt base in the intestine. However, DCAMKL1-positive cells have been shown to be differentiated tuft cellsrather than quiescent progenitors. Tuft cells are the onlyepithelial cells that express cyclooxygenase 2 (COX-2) in thenormal intestinal epithelium. We previously generated Cdx2-transgenic mice as model mice for intestinal metaplasia andgastric carcinoma. In the current study, we investigated theassociation between COX-2 and DCAMKL1 in gastric carcinoma. Methods: We examined the association between COX-2 and DCAMKL1 expression in gastric carcinomas in clinicalsamples (early gastric well-differentiated adenocarcinoma)and Cdx2-transgenic mice; and the DCAMKL1-transgenicmouse stomach using immunohistochemistry and quantitativereal-time polymerase chain reaction. Results: The COX-2-expressing cells were scattered, not diffusely expressed, ingastric carcinomas from humans and Cdx2-transgenic mice. DCAMKL1-positive cells were also scattered in the gastriccarcinomas, indicating that tuft cells could still be presentin gastric carcinoma. COX-2 was expressed in DCAMKL1-positive tuft cells in Cdx2- and DCAMKL1-transgenic mousestomachs, whereas the Sox9 transcription factor was ubiquitouslyexpressed in gastric carcinomas, including COX-2-positive cells. Conclusions: COX-2 is expressed in DCAMKL1-expressing quiescent tuft cells in gastric carcinoma.
참고문헌 (38)
- Gerbe F, "DCAMKL-1 expression identifies Tuft cells rather than stem cells in the adult mouse intestinal epithelium", Gastroenterology, 137, pp.2179~2180 (2009)
- Gerbe F, "Distinct ATOH1 and Neurog3 requirements define tuft cells as a new secretory cell type in the intestinal epithelium", J Cell Biol, 192, pp.767~780 (2011)
- Sashikawa Kimura M, "SOX9 is expressed in normal stomach, intestinal metaplasia, and gastric carcinoma in humans", J Gastroenterol, 46, pp.1292~1299 (2011)
- Blache P, "SOX9 is an intestine crypt transcription factor, is regulated by the Wnt pathway, and represses the CDX2 and MUC2 genes", J Cell Biol, 166, pp.37~47 (2004)
- Jay P, "Expression of the carcinoembryonic antigen gene is inhibited by SOX9 in human colon carcinoma cells", Cancer Res, 65, pp.2193~2198 (2005)
- Sato A, "Tuft cells", Anat Sci Int, 82, pp.187~199 (2007)
- Bezençon C, "Murine intestinal cells expressing Trpm5 are mostly brush cells and express markers of neuronal and inflammatory cells", J Comp Neurol, 509, pp.514~525 (2008)
- Ristimäki A, "Expression of cyclooxygenase-2 in human gastric carcinoma", Cancer Res, 57, pp.1276~1280 (1997)
- Uefuji K, "Expression of cyclooxygenase-2 protein in gastric adenocarcinoma", J Surg Oncol, 69, pp.168~172 (1998)
- Yamamoto H, "Overexpression of cyclooxygenase-2 protein is less frequent in gastric cancers with microsatellite instability", Int J Cancer, 84, pp.400~403 (1999)
- Lin PT, "DCAMKL1 encodes a protein kinase with homology to doublecortin that regulates microtubule polymerization", J Neurosci, 20, pp.9152~9161 (2000)
- Ohno R, "Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma", Cancer, 91, pp.1876~1881 (2001)
- Shi H, "Prognostic significance of expression of cyclooxygenase-2 and vascular endothelial growth factor in human gastric carcinoma", World J Gastroenterol, 9, pp.1421~1426 (2003)
- Murata H, "Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma", Am J Gastroenterol, 94, pp.451~455 (1999)
- Chen JH, "Effects of COX-2 inhibitor on growth of human gastric cancer cells and its relation to hepatocyte growth factor", Cancer Lett, 239, pp.263~270 (2006)
- Yeh TS, "The activated Notch1 signal pathway is associated with gastric cancer progression through cyclooxygenase-2", Cancer Res, 69, pp.5039~5048 (2009)
- Hsu KW, "MBP-1 suppresses growth and metastasis of gastric cancer cells through COX-2", Mol Biol Cell, 20, pp.5127~5137 (2009)
- Hu PJ, "Chemoprevention of gastric cancer by celecoxib in rats", Gut, 53, pp.195~200 (2004)
- Lee DS, "COX-2 inhibition and the prevention of gastric cancer", Digestion, 74, pp.184~186 (2006)
- Jiang XH, "Cyclooxygenase-2 inhibition and gastric cancer", Curr Pharm Des, 9, pp.2281~2288 (2003)
- Fujimura T, "Role of cyclooxygenase-2 in the carcinogenesis of gastrointestinal tract cancers: a review and report of personal experience", World J Gastroenterol, 12, pp.1336~1345 (2006)
- Saukkonen K, "Cyclooxygenase-2 expression and effect of celecoxib in gastric adenomas of trefoil factor 1-deficient mice", Cancer Res, 63, pp.3032~3036 (2003)
- Correa P, "Human gastric carcinogenesis: a multistep and multifactorial process: first American Cancer Society Award lecture on cancer epidemiology and prevention", Cancer Res, 52, pp.6735~6740 (1992)
- Correa P, "Helicobacter pylori and gastric carcinoma: serum antibody prevalence in populations with contrasting cancer risks", Cancer, 66, pp.2569~2574 (1990)
- Mutoh H, "Conversion of gastric mucosa to intestinal metaplasia in Cdx2-expressing transgenic mice", Biochem Biophys Res Commun, 294, pp.470~479 (2002)
- Mutoh H, "Cdx2 specifies the differentiation of morphological as well as functional absorptive enterocytes of the small intestine", Int J Dev Biol, 49, pp.867~871 (2005)
- Mutoh H, "Development of gastric carcinoma from intestinal metaplasia in Cdx2-transgenic mice", Cancer, 64, pp.7740~7747 (2004)
- Mutoh H, "Direct repression of Sonic hedgehog expression in the stomach by Cdx2 leads to intestinal transformation", Biochem J, 427, pp.423~434 (2010)
- Livak KJ, "Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method", Methods, 25, pp.402~408 (2001)
- Giannakis M, "Molecular properties of adult mouse gastric and intestinal epithelial progenitors in their niches", J Biol Chem, 281, pp.11292~11300 (2006)
- May R, "Doublecortin and CaM kinase-like-1 and leucine-rich-repeat-containing G-protein-coupled receptor mark quiescent and cycling intestinal stem cells, respectively", Stem Cells, 27, pp.2571~2579 (2009)
- Montgomery RK, "Small intestinal stem cell markers", J Anat, 213, pp.52~58 (2008)
- Reya T, "Stem cells, cancer, and cancer stem cells", Nature, 414, pp.105~111 (2001)
- Bonnet D, "Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell", Nat Med, 3, pp.730~737 (1997)
- Janssen KP, "Targeted expression of oncogenic K-ras in intestinal epithelium causes spontaneous tumorigenesis in mice", Gastroenterology, 123, pp.492~504 (2002)
- Colnot S, "Colorectal cancers in a new mouse model of familial adenomatous polyposis: influence of genetic and environmental modifiers", Lab Invest, 84, pp.1619~1630 (2004)
- Sureban SM, "Nanoparticle-based delivery of siDCAMKL-1 increases MicroRNA-144 and inhibits colorectal cancer tumor growth via a Notch-1 dependent mechanism", J Nanobiotechnol, 9, pp.40~ (2011)
- Giannakis M, "Helicobacter pylori evolution during progression from chronic atrophic gastritis to gastric cancer and its impact on gastric stem cells", Proc Natl Acad Sci U S A, 105, pp.4358~4363 (2008)
